文献速递关节外科

初次全膝关节置换术后口服泼尼松不增加感染,但可能与较高的内科和外科并发症风险相关

Oral Prednisone Use Following Primary Total Knee Arthroplasty Does Not Increase Infections, but can be Associated With Higher Risk for Medical and Surgical Complications.
PubMed 文献 · J Arthroplasty · 2024-05-24

基于全国行政索赔数据库纳入949555例初次全膝关节置换患者,急性泼尼松使用(术后30天内仅开具泼尼松处方)与麻醉下手法松解、粘连松解、急性肾损伤和肺炎的调整比值比升高相关,但感染发生率未增加。结论认为术后短期使用泼尼松可能与某些内外科并发症发生率较高相关,但感染风险未增加,术后泼尼松使用的最佳患者特征仍有待明确。

要点

  • 急性泼尼松使用与麻醉下手法松解调整OR=1.23(95%CI 1.09-1.38;P<.001)相关。
  • 急性泼尼松使用与肺炎调整OR=4.04(95%CI 3.53-4.59;P<.001)和急性肾损伤调整OR=1.47(95%CI 1.25-1.71;P<.001)相关。
  • 急性泼尼松使用未增加感染发生率;术后泼尼松使用的最佳患者特征仍有待明确。

核心结论

  • 全膝关节置换术后短期内使用泼尼松可能与某些外科和内科并发症发生率较高相关,但感染风险未增加。
  • 鉴于这些风险,术后泼尼松使用的最佳患者特征仍有待明确。

研究设计与样本

  • 使用全国行政索赔数据库识别949555例接受初次全膝关节置换的患者。
  • 排除术前90天内或术后90至364天之间开具口服泼尼松处方的患者。
  • 急性泼尼松使用定义为仅在术后30天内开具泼尼松处方。
  • 采用多变量逻辑回归模型评估急性泼尼松使用与并发症之间的关联,并调整年龄、性别、地区、保险计划和Elixhauser合并症。

主要发现

  • 急性泼尼松使用组患者后续麻醉下手法松解的调整比值比高于无急性泼尼松使用患者,调整OR=1.23(95%CI 1.09-1.38;P<.001)。
  • 急性泼尼松使用组患者粘连松解的调整比值比高于无急性泼尼松使用患者,调整OR=1.58(95%CI 1.02-2.33;P=.03)。
  • 急性泼尼松使用组患者急性肾损伤的调整比值比高于无急性泼尼松使用患者,调整OR=1.47(95%CI 1.25-1.71;P<.001)。
  • 急性泼尼松使用组患者肺炎的调整比值比高于无急性泼尼松使用患者,调整OR=4.04(95%CI 3.53-4.59;P<.001)。
  • 感染发生率未增加。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative use of oral prednisone to augment the effect of multimodal pain regimens after total knee arthroplasty (TKA) has increased in popularity. However, data on the risks of its utilization, especially as it relates to infection, have been lacking. We tested the null hypothesis that perioperative prednisone use is not associated with the incidence of surgical and medical complications after TKA. METHODS: Using a national administrative claims database, we identified 949,555 patients undergoing primary TKA. We excluded patients who filled oral prednisone prescriptions within 90 days prior to surgery or between 90 and 364 days after surgery. Patients who had acute prednisone use were defined as those who filled prednisone prescriptions only within 30 days after surgery. Outcomes consisted of surgical and medical complications after TKA. Multivariable logistic regression models were used to evaluate the association between acute prednisone use and complications, adjusting for age, sex, region, insurance plan, and Elixhauser comorbidities. RESULTS: Patients in the acute prednisone cohort had greater adjusted odds of subsequent manipulation under anesthesia (adjusted odds ratio [OR] = 1.23 [95% confidence interval {CI}: 1.09 to 1.38]; P < .001) and lysis of adhesions (adjusted OR = 1.58 [95% CI: 1.02 to 2.33]; P = .03) compared to patients who did not have acute prednisone use. Patients who had acute prednisone use also had greater adjusted odds of acute kidney injury (adjusted OR = 1.47 [95% CI: 1.25 to 1.71]; P < .001) and pneumonia (adjusted OR = 4.04 [95% CI: 3.53 to 4.59]; P < .001). There was no increased incidence of infection. CONCLUSIONS: Prednisone use shortly following TKA may be associated with a higher incidence of certain surgical and medical complications, but without increased risk for infection. However, given these risks, the optimal patient profile for postoperative prednisone use remains to be defined.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Zhuang T, Stein M, Dehghani B, et al. Oral Prednisone Use Following Primary Total Knee Arthroplasty Does Not Increase Infections, but can be Associated With Higher Risk for Medical and Surgical Complications. J Arthroplasty. 2024. PMID: 38797443. doi:10.1016/j.arth.2024.05.061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。